“Deerfield Special Situations International Master Fund, L.P.”

a.k.a.:  “Deerfield Special Situations International Master Fund, L.P”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  2/16/16  as  ↓Group Member

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Deerfield Special Situations International Master Fund, L.P.” has been a Group Member with  one  Filer:

        

“Deerfield Special Situations International Master Fund, L.P.” has/had a Group Member interest in  69  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
2/16/16		NC	Aerie Pharmaceuticals Inc.	3	SC 13G/A	NY	Flynn James E
2/16/16			Horizon Therapeutics plc	4	SC 13G/A	NY	Flynn James E
2/16/16		DC	Vanda Pharmaceuticals Inc.	3	SC 13G/A	NY	Flynn James E
2/16/16		NC	Tengion Inc.	4	SC 13G/A	NY	Flynn James E
2/16/16			Prosensa Holding N.V. in liquidatie	4	SC 13G/A	NY	Flynn James E
2/16/16		NJ	Palatin Technologies Inc.	3	SC 13G/A	NY	Flynn James E
2/16/16		NJ	Humanigen, Inc.	3	SC 13G/A	NY	Flynn James E
2/16/16		PA	Windtree Therapeutics Inc./DE	4	SC 13G/A	NY	Flynn James E
2/16/16		CA	CareDx, Inc.	3	SC 13G/A	NY	Flynn James E
2/16/16		CT	Cara Therapeutics, Inc.	3	SC 13G/A	NY	Flynn James E
2/16/16		CA	WaferGen Bio-systems, Inc.	4	SC 13G/A	NY	Flynn James E
2/16/16		CA	Adverum Biotechnologies, Inc.	3	SC 13G/A	NY	Flynn James E
2/16/16		CA	Anthera Pharmaceuticals Inc.	5	SC 13G/A	NY	Flynn James E
2/16/16		WA	Trupanion, Inc.	3	SC 13G/A	NY	Flynn James E
2/16/16		CA	TriVascular Technologies, Inc.	3	SC 13G/A	NY	Flynn James E
2/16/16		NJ	Scynexis Inc.	3	SC 13G/A	NY	Flynn James E
2/16/16		NY	Protara Therapeutics, Inc.	3	SC 13G/A	NY	Flynn James E
2/16/16		MA	NxStage Medical, Inc.	4	SC 13G/A	NY	Flynn James E
2/16/16		NY	Synergy Pharmaceuticals LLC	3	SC 13G/A	NY	Flynn James E
2/16/16		CT	Cas Medical Systems Inc.	2	SC 13G/A	NY	Flynn James E
			More...  Please Sign In to list all 69 of them.

“Deerfield Special Situations International Master Fund, L.P.” has been a Group Member with  16  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
2/16/16		NY	Deerfield International Master Fund, L.P.	56	SC 13G/A	NY	Flynn James E	NC	Aerie Pharmaceuticals Inc.
		•	Deerfield Management Co., L.P	171
		•	Deerfield Management Company, L.P.	169
		NY	Deerfield Mgmt III, L.P.	13
		NY	Deerfield Mgmt, L.P.	169
		NY	Deerfield Partners, L.P.	56
		NY	Deerfield Private Design Fund III, L.P.	13
		NY	Deerfield Special Situations Fund. L.P.	171
2/16/16		NY	Deerfield Private Design Fund II, L.P.	42	SC 13G/A	NY	Flynn James E		Horizon Therapeutics plc
			Deerfield Private Design International II, L.P.	42
2/16/16		NY	Deerfield Private Design Fund, L.P.	10	SC 13G/A	NY	Flynn James E	CA	Pacific Biosciences of California, Inc.
		NY	Deerfield Private Design International, L.P.	10
1/4/16		NY	Breaking Stick Holdings, LLC	4	SC 13G/A	NY	Flynn James E		Avadel Pharmaceuticals plc
		NY	James E. Flynn	4
8/2/12			Deerfield Special Situations Fund International, Ltd.	3	SC 13G	NY	Flynn James E	CA	Anthera Pharmaceuticals Inc.
7/26/12		MA	Deerfield Capital, L.P.**	2	SC 13G	NY	Flynn James E	NH	Icad Inc.